AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
66.11
-0.48 (-0.72%)
At close: Apr 28, 2026, 4:00 PM EDT
66.11
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
AnaptysBio Employees
AnaptysBio had 104 employees as of December 31, 2025. The number of employees decreased by 32 or -23.53% compared to the previous year.
Employees
104
Change (1Y)
-32
Growth (1Y)
-23.53%
Revenue / Employee
$2,255,798
Profits / Employee
-$127,231
Market Cap
1.90B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Recursion Pharmaceuticals | 600 |
| Galapagos NV | 558 |
| Vericel | 398 |
| Syndax Pharmaceuticals | 298 |
| Stoke Therapeutics | 170 |
| Pharvaris | 129 |
| Inhibrx Biosciences | 110 |
| Taysha Gene Therapies | 99 |
ANAB News
- 4 days ago - Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro's Anticipatory Breach Claim - GlobeNewsWire
- 8 days ago - Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations - GlobeNewsWire
- 4 weeks ago - Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics - GlobeNewsWire
- 4 weeks ago - Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update - GlobeNewsWire
- 4 weeks ago - First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement - GlobeNewsWire
- 6 weeks ago - AnaptysBio Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - AnaptysBio Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 7 weeks ago - AnaptysBio Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts